$BLUE Read the whole 10K filing for ER. Could not be happier, Looks like ide-cel bb2121 - KarMMa is a slam dunk in March with the FDA. Also they've updated to say FDA has chosen LentiGlobin suspension into a HOLD! BIG NEWS people clearly didn't clock! Also below we have BLAs for H2 ON CALD pipeline. Revenue of $10.71M (+7.2% Y/Y)